Wolfe Research Upgrades Intellia Therapeutics (NTLA) to Outperform

Go back to Wolfe Research Upgrades Intellia Therapeutics (NTLA) to Outperform
(NASDAQ: NTLA) Delayed: 11.83 -0.26 (2.15%)
Previous Close $12.09    52 Week High $30.40 
Open $12.10    52 Week Low $11.86 
Day High $12.17    P/E N/A 
Day Low $11.81    EPS $0.00 
Volume 2,945,209